MRKMerck

Each row is one issuer’s token for Merck, with the chains it is deployed on. A bold chain is one where these wallets hold a balance. Tokens are not shares: no issuer in the registry publishes a shares-per-token ratio, so a balance is counted one per share and marked where that assumption is doing work.

Tokenized versions of Merck, the issuer behind each, the chains it is deployed on, and what these wallets hold of it.

Token	Issuer	Chains	You hold
MRKon	Ondo	ETHBNBSOL	0.00001*$0.00
MRK	Dinari	ETHARBBASEAVAX	—

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

Type

Common stock

Sector

Healthcare › Pharmaceuticals

Exchange

NYSE

Listed since

Apr 20, 1949

Shares outstanding

2.47B

Employees

75,000

As the market data provider names it. Where that differs from the issuers’ name for the security, both are shown so the difference is visible.